[23] Watjen F., Baker R., Engelstoff M., Herbert R., MacLeod A., Knight A., Merchant K., Moseley J., Saunders J.,
Novel Benzodiazepine Receptor Partial Agonists: Oxadiazolylimidazobenzodiazepines,
J. Med. Chem. 32: 2282 (1989).
[29] Gilman N. W., Rosen P., Earley J. V., Cook C. M., Blount J. F., Todaro L. J.,
Atropisomers of 1,4-benzodiazepines Synthesis and Resolution of Imidazo[1,5-a][1,4]benzodiazepines,
J. O. C.,
58: 3285-3298 (1993).
[31] Cook M., Huang Q., He X., Li X., Yu J., Han D., McElroy J. F.,
Anxiolytic Agents with Reduced Sedative and Ataxic Effects, U.S. Patent No. 7,119,196 (2006).
[36] Cheng P., Zhang Q., Ma Y. B., Jiang Z. Y., Zhang X. M., Zhang F. X., Chen J. J.,
Synthesis and in Vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives, Bioorg. Med. Chem. Lett,
18; 3787 (2008).
[45] Walser A., Benjamin L., Flynn T., Mason C., Schwartz R., Fryer R.,
Quinazolines and 1,4-Benzodiazepines. 84. Synthesis and Reactions of imidazo[1,5-a][1,4]benzodiazepines,
J. Org. Chem,
43: 936 (1978).
[46] Bock M.G., Di Pardo R.M., Evans B.E., Rittle K.E., Veber D.F., Freidinger R. M., Hirshfield J.,
Synthesis and Resolution of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones,
J. Org. Chem,
52: 3232 (1987).
[47] Gu Z. Q., Wong G., Dominguez C., de Costa B. R., Rice K. C., Skolnick P.,
Synthesis and Evaluation of Imidazo[1,5-a][1,4]benzodiazepine Esters with High Affinities and Selectivities at "Diazepam-Insensitive" Benzodiazepine Receptors,
J. Med. Chem,
36: 1001 (1993).